Expertise in
19
conditions

Dr. Michi M. Shinohara

Dermatology
Rachel Loschiavo PA-C
825 Eastlake Ave E, 
Seattle, WA 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Offers Telehealth
Referral may be required
Before you request
Expertise in
19
conditions
Rachel Loschiavo PA-C
825 Eastlake Ave E, 
Seattle, WA 

Overview

Michi Shinohara is a Dermatologist practicing medicine in Seattle, Washington.

Dr. Shinohara is highly rated in 19 conditions, according to our data. Her clinical expertise encompasses Cutaneous T-Cell Lymphoma (CTCL), T-Cell Lymphoma, Mycosis Fungoides, and Lymphomatoid Papulosis.

She is actively involved in clinical research, co-authoring 123 peer reviewed articles and participating in 3 clinical trials. Dr. Shinohara is currently accepting new patients.

Specialties

Dermatology

Licenses

Dermatology in WA

Hospital Affiliations

University Of Washington Medical Ctr
Harborview Medical Center

Languages Spoken

English
Castilian
Hungarian
Spanish
Vietnamese

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Community Health
  • EPO
  • HMO
Coordinated Care
  • HMO
  • MANAGED MEDICAID PLAN
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Moda Health
  • EPO
  • PPO
PacificSource
  • PPO
Premera
  • EPO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 12 Less Insurance Carriers -

Locations

Rachel Loschiavo Pa-C
825 Eastlake Ave E, Seattle, WA 98109
Other Locations
Headache Clinic At Uw Medical Center-Roosevelt
4225 Roosevelt Way NE, Seattle, WA 98105

Additional Areas of Focus

Dr. Shinohara has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Neurofibromatosis Type 1 (NF1)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris
A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris
Enrollment Status: Recruiting
Publish Date: May 29, 2026
Intervention Type: Biological
Study Drug: Autologous Desmoglein 3 CAR-T Cells
Study Phase: Phase 1/Phase 2
A Double Blind Randomized Vehicle Controlled Crossover Study to Evaluate the Safety and Efficacy of Topical Naloxone Hydrochloride Lotion 0.5% for the Relief of Pruritus in Patients With the MF or SS Forms of Cutaneous T-Cell Lymphoma
A Double Blind Randomized Vehicle Controlled Crossover Study to Evaluate the Safety and Efficacy of Topical Naloxone Hydrochloride Lotion 0.5% for the Relief of Pruritus in Patients With the MF or SS Forms of Cutaneous T-Cell Lymphoma
Enrollment Status: Terminated
Publish Date: October 28, 2022
Intervention Type: Drug
Study Drug: Naloxone Hydrochloride Lotion
Study Phase: Phase 3
SOLAR: A Phase 2, Randomized, Open-label, Parallel-group, Active Comparator, Multi-center Study to Investigate the Efficacy and Safety of Cobomarsen (MRG-106) in Subjects With Cutaneous T-Cell Lymphoma (CTCL), Mycosis Fungoides (MF) Subtype
SOLAR: A Phase 2, Randomized, Open-label, Parallel-group, Active Comparator, Multi-center Study to Investigate the Efficacy and Safety of Cobomarsen (MRG-106) in Subjects With Cutaneous T-Cell Lymphoma (CTCL), Mycosis Fungoides (MF) Subtype
Enrollment Status: Terminated
Publish Date: April 08, 2022
Intervention Type: Drug
Study Phase: Phase 2
View 2 Less Clinical Trial

123 Total Publications

Qualitative assessment of the content validity of pruritus patient-reported outcome measures in mycosis fungoides and Sézary syndrome.
Qualitative assessment of the content validity of pruritus patient-reported outcome measures in mycosis fungoides and Sézary syndrome.
Journal: The British journal of dermatology
Published: April 08, 2026
Similar Doctors
Expertise in
1
conditions
Dr. Tomoko Akaike
Dermatology
Expertise in
1
conditions
Dr. Tomoko Akaike
Dermatology
Referral required
Before you request

Headache Clinic At Uw Medical Center-Roosevelt

4225 Roosevelt Way NE, 
Seattle, WA 
 (2.3 miles away)
206-598-4067
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Tomoko Akaike is a Dermatologist practicing medicine in Seattle, Washington. Dr. Akaike is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Merkel Cell Carcinoma. Dr. Akaike is currently accepting new patients.

Expertise in
20
conditions
Dr. Vivian Y. Shi
Dermatology
Expertise in
20
conditions
Dr. Vivian Y. Shi
Dermatology
Referral may be required
Before you request

Headache Clinic At Uw Medical Center-Roosevelt

4225 Roosevelt Way NE, 
Seattle, WA 
 (2.3 miles away)
206-598-4067
Languages Spoken:
English, Mandarin
See accepted insurances
Accepting New Patients
Offers Telehealth

Vivian Shi is a Dermatologist practicing medicine in Seattle, Washington. Dr. Shi is highly rated in 20 conditions, according to our data. Her clinical expertise encompasses Hidradenitis Suppurativa, Atopic Dermatitis, Dissecting Cellulitis of the Scalp, and Contact Dermatitis. Dr. Shi is currently accepting new patients.

Expertise in
2
conditions
Dr. Paul T. Nghiem
Dermatology
Expertise in
2
conditions
Dr. Paul T. Nghiem
Dermatology
Referral required
Before you request

Rachel Loschiavo PA-C

825 Eastlake Ave E, 
Seattle, WA 
 (0.1 miles away)
855-557-0555
Languages Spoken:
English, Hindi, Japanese, Mandarin, Russian, Spanish, Ukrainian
See accepted insurances
Accepting New Patients
Offers Telehealth

Paul Nghiem is a Dermatologist practicing medicine in Seattle, Washington. Dr. Nghiem is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Merkel Cell Carcinoma, Squamous Cell Skin Carcinoma, Eccrine Porocarcinoma, and Melanoma. Dr. Nghiem is currently accepting new patients.

Frequently Asked Questions about Dr. Michi M. Shinohara

How do I make an appointment with Dr. Michi M. Shinohara?

You can book an appointment with Dr. Michi M. Shinohara by calling their office at 855-557-0555. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Michi M. Shinohara a top-rated expert for Cutaneous T-Cell Lymphoma (CTCL)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Michi M. Shinohara is classified as an Elite expert for Cutaneous T-Cell Lymphoma (CTCL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Michi M. Shinohara specialize in?

While Dr. Michi M. Shinohara is a Dermatology, they have specific expertise in Cutaneous T-Cell Lymphoma (CTCL), T-Cell Lymphoma, and Mycosis Fungoides. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Dermatology.

Does Dr. Michi M. Shinohara participate in research or clinical trials?

Yes. Dr. Michi M. Shinohara has published 123 articles and abstracts on conditions like Cutaneous T-Cell Lymphoma (CTCL). You can view a list of Dr. Michi M. Shinohara's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Michi M. Shinohara accept my insurance?

Dr. Michi M. Shinohara accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 855-557-0555 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Shinohara's expertise for a condition
ConditionClose
View All 12 Advanced Conditions
View All 55 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile